Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Merck KGaA : May Sell Allergopharma for up to USD638 Million

11/27/2015 | 12:35am US/Eastern
Deal Type: Acquisition
Deal Sub Type: 100% Acquisition
Deal Country: Germany
Deal Status: Rumor
Deal Value: 0.0000 USD

Deal in Brief

Merck KGaA, a chemical, pharmaceutical and life sciences company, intends to sell Allergopharma Joachim Ganzer KG, a manufacturer of diagnostics and prescription drugs for allergen immunotherapy (AIT), according to Bloomberg, citing people familiar with the matter. Reportedly, the transaction is expected to be valued about EUR600 million (USD637.92 million). This divestment will enable Merck to reduce debt following the acquisition of Sigma-Aldrich Corp for USD17 billion.

Index - Allergies
Index - Germany
Index - House Dust Mite Allergy
Index - Type I Hypersensitivity
Index - Pollen Allergy
Index - Birch Pollen Allergy
Index - Grass Pollen Allergy

(c) 2015 Progressive Media Group Metadata. All rights reserved. Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Progressive Media Group Metadata shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon., source PDM Deals

React to this article
Latest news on MERCK KGAA
12:35a MERCK KGAA : May Sell Allergopharma for up to USD638 Million
11/26 MERCK KGAA : plans to sell its allergy business unit to cut debt: Bloomberg
11/26 MERCK KGAA : Gray Modules: New Dimension in Organic Photovoltaics for Buildings
11/25 MERCK KGAA : Study Findings from Merck KGaA Provide New Insights into Chromatogr..
11/25 MERCK KGAA : and Pfizer Receive Positive Opinion for Orphan Drug Designation for..
11/20 MERCK KGAA : compte sur l’Afrique pour sa croissance • Le Conseil d&r..
11/20 MERCK KGAA : Counts on Africa for Growth • Executive Board wraps up week of..
11/20 MERCK KGAA : Counts on Africa for Growth
11/19 MERCK KGAA : Reports from Merck KGaA Add New Data to Findings in Physiology and ..
11/19 MERCK KGAA : and the University of Cape Town to Develop a Drug Discovery Platfor..
News chart
Full-screen chart
Income Statement Evolution
More Financials